Immune Checkpoint Inhibitors, The Next Generation Cancer Therapy - Creative Biolabs

Immune checkpoints act as homeostatic regulators of the immune system, and are crucial for maintaining immune tolerance. In tumor microenvironment (TME), tumor cells “hijack” the inhibitory mechanisms to avoid being eliminate. Immunotherapeutics that block these checkpoints have marked a revolution in the treatment of cancer and immunological diseases.

Creative Biolabs offers immune checkpoint inhibitor preclinical development services, covering antibodies, small molecule compounds, and peptides.